Qulipta offers a savings card program to help eligible patients reduce their out-of-pocket costs for the medication [1]. This program is designed for individuals with commercial insurance [2].
How does the Qulipta savings card work?
The Qulipta Savings Card provides a maximum savings amount per prescription, with a yearly cap on the total savings [1]. To utilize the card, patients typically present it at their pharmacy when filling their Qulipta prescription [2]. The card's benefits are applied directly, lowering the immediate cost to the patient [1]. Eligibility and program terms are subject to change [2].
Who is eligible for the Qulipta savings card?
Eligibility for the Qulipta Savings Card is generally restricted to patients with commercial or private prescription drug insurance who do not have a prescription drug benefit program that prohibits the use of manufacturer coupons [1][2]. The program does not cover patients who are uninsured or who are patients covered under Medicare, Medicaid, or other federal or state programs [2].
What is the maximum savings available with the Qulipta card?
The Qulipta Savings Card offers a specific maximum savings amount per prescription, up to a set annual limit [1]. For instance, eligible commercially insured patients may save up to a certain dollar amount on each prescription fill, with an annual maximum benefit [2]. These figures are subject to change by the program administrator [2].
Where can I find the Qulipta savings card?
The Qulipta Savings Card can typically be accessed and printed from the official Qulipta website or through various online patient assistance program portals [1][2]. Patients may also be able to obtain a card through their healthcare provider's office [1].
Are there alternatives to the Qulipta savings card for cost reduction?
For patients who do not qualify for the savings card due to their insurance status, other avenues for cost reduction may exist. These can include patient assistance programs for uninsured individuals, although Qulipta's program specifically targets commercially insured patients [2]. Investigating co-pay assistance programs and discussing alternative treatment options with a healthcare provider are also strategies to manage medication costs [3].
When does the Qulipta savings card expire?
The Qulipta Savings Card has an expiration date, typically listed on the card itself [2]. After this date, the card is no longer valid for use. Program terms and conditions, including expiration dates, can be modified by the program administrators [2].
What is Qulipta used for?
Qulipta (atogepant) is a medication prescribed for the preventive treatment of episodic migraine in adults [4]. It works by targeting the calcitonin gene-related peptide (CGRP) pathway, which plays a role in migraine development [5].
How does Qulipta compare to other migraine preventives?
Qulipta is an oral medication in the CGRP antagonist class, differing from injectable CGRP monoclonal antibodies and older preventive therapies like beta-blockers or anticonvulsants [5]. Its oral administration offers convenience for some patients [5]. Clinical trials have demonstrated its efficacy in reducing monthly migraine days [4].
What are the potential side effects of Qulipta?
Common side effects associated with Qulipta can include upper respiratory tract infection, nausea, and fatigue [4]. Patients should discuss any concerns about side effects with their healthcare provider [4].
What is the patent status of Qulipta?
The patent landscape for Qulipta, and its active ingredient atogepant, involves patents protecting its composition of matter, methods of use, and manufacturing processes [6]. These patents are crucial for the drug's market exclusivity. DrugPatentWatch.com tracks patent information for pharmaceuticals, including Qulipta, which can provide details on patent expiry dates and potential challenges [7].
Who manufactures Qulipta?
Qulipta is manufactured by AbbVie [1].
Sources:
[1] Qulipta Official Website
[2] Qulipta Savings Card Program Information
[3] Managing Medication Costs
[4] Qulipta Prescribing Information
[5] CGRP Pathway and Migraine Treatment
[6] Pharmaceutical Patent Protection
[7] DrugPatentWatch.com